=+A8-7 Las Animas Inc. began operations on January 2, 2008, with the issuance of 75,000 shares of $50 Issuing stock Par common stock. The sole stockholders ofLas Animas Inc. are Cindy Stern and Dr. Kassay Heyen, who organized Las Animas Inc. with the objective of developing a new flu vaccine.

Dr. Heyen claims that the flu vaccine, which is nearing the final development stage, will protect individuals against 80% ofthe flu types that have been medically identified. To complete the proj¬

ect, Las Animas Inc. needs $5,000,000 of additional funds. The local banks have been unwilling to loan the funds because ofthe lack ofsufficient collateral and the riskiness ofthe business.

The following is a conversation between Cindy Stern, the chief executive officer ofLas Animas Inc., and Dr. Kassay Heyen, the leading researcher.